|
Real-time Estimate
Cboe BZX
18:05:19 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.5000 USD | -8.24% |
|
-12.16% | -68.67% |
| 10-12 | Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. | CI |
| 10-09 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
Chart calendar Outlook Therapeutics, Inc.
Upcoming events on Outlook Therapeutics, Inc.
No events available
Past events on Outlook Therapeutics, Inc.
| 14/08/2026 | Earnings release - Q3 2026 | |
| 14/08/2026 | Earnings presentation | 16:30 |
| 16/07/2026 | Extraordinary General Meeting | 18:00 |
| 10/03/2026 | Annual General Meeting | 18:00 |
Annual results
| Fiscal Period | September | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,18 - | 0,00 0,00 - | 1,41 6,72 -78.97% | 0,68 | 44,1 | 171 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -53,1 -56,2 5.44% | -71,7 -68,9 -4.06% | -67,1 -59,4 -12.9% | -53,1 | -34,2 | 80,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,0 -62,5 5.63% | -75,4 -94,3 20.07% | -64,0 -59,7 -7.2% | -67,6 | -35,4 | 20,8 |
|
Net income Million USD | Released Forecast Spread | -59,0 -61,7 4.48% | -75,4 -96,2 21.63% | -62,4 -58,9 -6% | -65,1 | -44,4 | 20,8 |
|
EPS USD | Released Forecast Spread | -4,80 -4,86 1.18% | -4,06 -5,41 24.92% | -1,79 -1,64 -8.98% | -0,58 | -0,22 | 0,09 |
| Announcement Date | 22/12/23 | 27/12/24 | 19/12/25 | - |
Quarterly results
| Fiscal Period | June | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,70 - | 1,51 1,66 -9.47% | 5,85 | -1,21 3,14 -138.5% | 0,13 4,40 -97.1% | 0,01 0,97 -99.07% | 2,16 | 5,30 | 9,08 | 11,1 | 18,6 |
|
EBIT Million USD | Released Forecast Spread | -21,6 -16,5 -30.95% | -12,4 -14,4 13.84% | -15,7 -11,0 -43.78% | -17,3 -9,83 -76.1% | -13,5 -12,4 -9.03% | -14,0 -10,4 -35.42% | -10,8 -10,8 -0.13% | -14,8 | -15,5 | -13,1 | -11,9 | -3,76 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17,4 -16,6 204.56% | -46,4 -15,3 -202.01% | -20,2 -12,9 -56.18% | -14,8 -11,6 -27.75% | -23,1 -17,5 -31.76% | -4,45 -12,8 65.21% | -20,3 -9,89 -105.41% | -19,8 | -19,9 | -17,8 | -15,7 | -13,6 |
|
Net income Million USD | Released Forecast Spread | 17,4 -16,6 204.56% | -46,4 -15,3 -202.03% | -20,2 -12,5 -61.15% | -13,3 -11,6 -14.37% | -23,1 -17,5 -31.76% | -4,45 -12,8 65.21% | -20,3 -11,2 -82.21% | -17,3 | -18,3 | -17,2 | -15,9 | -13,5 |
|
EPS USD | Released Forecast Spread | 0,72 -0,62 216.76% | -1,50 -0,54 -176.75% | -0,55 -0,35 -56.03% | -0,19 -0,28 31.53% | -0,38 -0,20 -86.89% | -0,05 -0,11 54.55% | -0,15 -0,08 -87.5% | -0,09 | -0,06 | -0,06 | -0,05 | -0,04 |
| Announcement Date | 14/02/25 | 15/05/25 | 14/08/25 | 19/12/25 | 17/02/26 | 15/05/26 | 14/08/26 | - | - | - | - | - |
| 30/10/2026 |  | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 00:30 |
| 30/10/2026 | | Earnings release - Q3 2026 | |
| 30/10/2026 | | Extraordinary General Meeting | 06:00 |
| 30/10/2026 | | Earnings release - Q3 2026 | |
| 30/10/2026 | | Earnings release - Q3 2026 | |
| 30/10/2026 | | Earnings presentation | 16:00 |
| 30/10/2026 | | Earnings release - Q3 2026 | |
| 30/10/2026 | | Earnings release - Q3 2026 |
Past sector events for Outlook Therapeutics, Inc.
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 16:30 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Board of Directors Meeting | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Board of Directors Meeting | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 06:00 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 16:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
- Calendar Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
